logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On April 2, SPRING REIT (01426) spent HK$268,600 to repurchase 170,000 fund units.

date
17:45 02/04/2026
avatar
GMT Eight
Chunquan Industry Trust (01426) issued an announcement that the fund purchased 170,000 fund units for 268,600 Hong Kong dollars on April 2, 2026, with a repurchase price of 1.58 Hong Kong dollars per unit.
SPRING REIT (01426) announced that the fund repurchased 170,000 fund units at a price of 1.58 Hong Kong dollars per unit, totaling 26.86 million Hong Kong dollars on April 2, 2026.
Related Articles
HK Stock
WINSHINE SCI (00209) appointed Guo Jianwei as an independent non-executive director.
HK Stock
XD INC (02400) spent HK$7.715 million on April 2 to repurchase 125,000 shares.
HK Stock
Page Biopharmaceuticals-B (02565): CR059 related research summary has been accepted and selected as the latest breakthrough abstract at the American Diabetes Association's 2026 Scientific Sessions.
WINSHINE SCI (00209) appointed Guo Jianwei as an independent non-executive director.
HK Stock
XD INC (02400) spent HK$7.715 million on April 2 to repurchase 125,000 shares.
HK Stock
Page Biopharmaceuticals-B (02565): CR059 related research summary has been accepted and selected as the latest breakthrough abstract at the American Diabetes Association's 2026 Scientific Sessions.
HK Stock
RECOMMEND
The “Google Panic” In Memory Stocks: New Cycle Dynamics Beneath Technological Headlines
The “Google Panic” In Memory Stocks: New Cycle Dynamics Beneath Technological Headlines
icon
01/04/2026
Price Increase Cycle Begins, Semiconductor Industry Enters New Stage Of Rising Volume And Value
Price Increase Cycle Begins, Semiconductor Industry Enters New Stage Of Rising Volume And Value
icon
01/04/2026
When Will Hong Kong Stocks Reach Their Low Point?
When Will Hong Kong Stocks Reach Their Low Point?
icon
01/04/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.